Grespo AB
Young biomedical company developing CNS treatments based on 2-oxoglutarate research.
Oversigt
- 0
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2006
- Grundlagt
Beskrivelse
Grespo is a young biomedical company based in Sweden specializing in the prevention and treatment of Central Nervous System (CNS) diseases. The core of their research focuses on leveraging the therapeutic effects of the substance 2-oxoglutarate (2-OX) within the body. Their primary clinical targets...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556710027501
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
ScandiBio Therapeutics AB
0 medarbejdereAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
LobSor Pharmaceuticals Aktiebolag
3 medarbejdereDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
Umecrine Cognition AB
1–4 medarbejdereDeveloping novel drugs for neurological disorders caused by neuroinflammation.
AlzeCure Pharma AB
10–19 medarbejdereSwedish pharma developing CNS drugs for Alzheimer's and pain.
Polku Therapeutics Oy
Developing novel therapies for debilitating neurodegenerative diseases.
Udforsk mere
Spørgsmål om Grespo AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo